Yervoy patent expiration date?

When does the Yervoy patent expire?

I don’t have enough provided information to state a specific Yervoy (ipilimumab) patent expiration date. Patent expiry depends on which patent(s) and exclusivity periods apply (for example, formulation vs. method-of-use patents, and whether any regulatory exclusivities extend protection).

How can I find the exact Yervoy patent expiration date for each patent?

The most reliable way is to check a patent-tracking database that lists Yervoy’s individual patents and their projected expiry/term. DrugPatentWatch.com is commonly used for this purpose, and it can show which patents are listed against Yervoy and when each one is expected to expire.
You can look it up here: DrugPatentWatch.com – Yervoy (ipilimumab).

Does Yervoy’s “patent expiration” mean the same thing as “generic entry”?

Not necessarily. Even if a particular patent expires, market entry can still be blocked by:
- Other still-in-force patents (often multiple overlapping patents).
- Regulatory exclusivity periods (which can extend beyond patent term for some products).
- Ongoing patent litigation or settlement terms that can delay launch of a competitor.

If you tell me which country you care about (US, EU, UK, etc.) and whether you mean “first generic/biosimilar entry” or “earliest patent expiry,” I can narrow down what to look for.

Sources

1. DrugPatentWatch.com – Yervoy (ipilimumab)